Improvement of Cardiac Diastolic Function and Prognosis After Autologous Peripheral Blood Stem Cell Transplantation in AL Cardiac Amyloidosis

Shusuke Yagi, Masashi Akaike, Shuji Ozaki, Chikako Moriya, Kyoko Takeuchi, Tomoko Hara, Mitsunori Fujimura, Yuka Sumitomo, Takashi Iwase, Yasumasa Ikeda, Ken-ichi Aihara, Takehiko Kimura (+3 others)
2007 Internal medicine (Tokyo. 1992)  
AL amyloidosis is a disease in which immunoglobulin L chain is deposited in multiple organs, and the prognosis of cardiac amyloidosis is extremely poor. Although several treatments based on that for multiple myeloma, have been performed, there is no clear evidence that cardiac function is improved. We report a case of AL cardiac amyloidosis with moderate cardiac dysfunction for which we performed autologous peripheral blood stem cell transplantation (auto-PBSCT) in combination with high-dose
more » ... phalan therapy. This treatment resulted in significant improvement in cardiac function and good prognosis for about 3.5 years after the diagnosis. Therefore, auto-PBSCT is a possible option as up-front therapy for AL cardiac amyloidosis. A 63-year-old woman visited a hospital because of palpitation in 2002. A 12-lead electrocardiography (ECG) revealed first-degree atrioventricular block and low voltage in the limb lead. Multifocal premature ventricular contractions were observed on a 24-
doi:10.2169/internalmedicine.46.0142 pmid:17938525 fatcat:bqmokrogwja4zhxasu7e2rryzi